Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA approves beetroot red food dye in latest MAHA push

The administration has asked companies to phase out artificial food dyes tied to behavioral problems in kids

The Independent UK

Stocks Roar Back as Beaten-Down Tech Sector Rebounds

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.97%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +2.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.15%. March E-mini S&P futures (ESH26 ) rose +1.92%, and March E-mini Nasdaq futures...

Barchart

How TrumpRx drug prices compare to generic alternatives

Patients could save more buying non-branded copycat drugs, even if they don't have insurance.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Olympic ski jumpers are rumored to have injected hyaluronic acid into their penises. What are the health risks?

As rumors swirl amid ‘Penisgate,’ the International Ski and Snowboard Federation says there’s no evidence to back up claims

The Independent UK

Stocks Supported by Tech Strength and Improvement in Consumer Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.93%. March E-mini S&P futures (ESH26 ) are up +1.14%, and March E-mini Nasdaq futures...

Barchart

Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. March E-mini S&P futures (ESH26 ) are up +1.21%, and March E-mini Nasdaq futures...

Barchart

US health company launches weight-loss pill that Novo Nordisk calls an 'untested knockoff'

The American telehealth company announced the launch of a compounded weight-loss pill for €41, drawing criticism from Novo Nordisk, the Danish company behind the weight-loss drug Wegovy, which called the product an “untested knockoff.”

Euronews

Read news from The Economist, FT, and more,
with one subscription

Federal and state authorities are taking a 2-pronged approach to make it harder to get an abortion

Anti-abortion conservatives have long sought to force Planned Parenthood’s clinics to close their doors and to make it harder, if not impossible, to get abortion pills as part of a two-pronged approach to limit access to abortion.

The Conversation

Thousands of M&M’s packages recalled by FDA across nearly two dozen states

More than 6,000 units were repackaged by Beacon Promotions Inc. without advisories that they may contain milk, soy and peanuts

The Independent UK

How GLP-1 drugs may be leading to new eating disorders

While other weight-loss drugs have caused similar problems, one expert said GLP-1 medications have a far greater impact

The Independent UK

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy

The Independent UK

Companies can now claim 'no artificial colors' if they add plant-based color to food

The U.S. Food and Drug Administration is relaxing rules that restrict when food companies can claim their products have no artificial colors

The Independent UK

‘People are turning themselves into lab rats’: the injectable peptides craze sweeping the US

Though lab-made peptides are touted as a cure-all, they are not FDA-regulated and pose serious risks, experts warn

The Guardian - US

The new ‘blue pill’: Honey energy supplement under recall for having ED medicine mixed in

The affected ED drug may cause heart issues, blood pressure changes, dizziness and headaches, particularly in people with health conditions or taking certain medications

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Experimental pill may offer new cholesterol-lowering option for millions

There are other pills that patients can add to their statin

Budget and the Bees

Salmonella Outbreak 2026: Check Your Pantry for These Two Common Health Supplements

Supplements are intended to boost health, but a recent multi-state Salmonella outbreak in 2026 has turned morning wellness routines into a significant risk. Two major “superfood” brands are currently at the center of a federal investigation. The FDA and CDC are tracking at least 65 illnesses across 28 states, with…

Budget and the Bees

Mouthwash Alert: 80,000 Bottles Recalled Due to Serious Labeling Error

Your morning hygiene routine is supposed to be the simplest part of your day. You reach for the bottle, rinse, and go. But a massive new recall of over 80,000 bottles of Parodontax Active Gum Health mouthwash has turned a basic habit into a potential risk. The FDA has issued…

Budget and the Bees

Fatal Botulism Risk: Recalled Tuna Inadvertently Shipped to Stores in 9 States

A simple sandwich shouldn’t be a gamble with your life, but for residents in nine states, the pantry staple in their kitchen could be a ticking time bomb. The FDA has issued a frantic update after a third-party distributor accidentally shipped thousands of cans of recalled Genova Yellowfin Tuna that…

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

House lawmaker raises new concerns over FDA's ultra-fast drug review program

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs

MarketBeat

BioTech Breakout: MoonLake Up 30% On FDA Wins

MoonLake shares are rallying after the FDA granted Fast Track designation for its lead drug and cleared the path for a major filing later this year.

Reason

How To Speed Up the Search for Cures Through a Change in Probability Theory

It seems likely the FDA would do well to accept more Bayesian reasoning in medical research.

Barchart

Up 460% in the Past Year, Should You Take a Gamble on This Speculative Stock?

Erasca (ERAS) has surged 460% over the past year, driven by strong technical momentum. ERAS hit a new 3-year high of $10.92 on Monday. Despite bullish technicals, ERAS has no revenue, is burning cash, and its future hinges on FDA drug approvals. Analyst sentiment is highly speculative, with price targets...

Budget and the Bees

FDA Red Alert: Why This Common Blood Pressure Medication Was Just Pulled

You trust that the pill bottle you pick up from the pharmacy is safe. You assume there are rigorous checks and balances before that medication reaches your hands. Unfortunately, the reality of the global pharmaceutical supply chain is far messier. Recently, the FDA issued a recall for the popular blood-pressure…

Euronews

Why Denmark can't use Ozempic as a trump card with the US in Greenland talks

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

Budget and the Bees

Health Alert: FDA Detects Multiple Pathogens, Dog Food Brand Won’t Recall Products

We treat our pets like family, often buying the most expensive “premium” food to ensure their health. But a disturbing standoff is currently unfolding between federal regulators and a well-known boutique dog food manufacturer.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.